Sign up
Agenda
A.Speech & Panel
08/11 W hotel 8F (Mega Room)
| Time | Speech & Panel | Speaker | Title |
| 08:30 ╷ 09:00 |
Check in | ||
| 09:00 ╷ 09:30 |
Opening Remarks | Pan-Chyr Yang | Chairman, Diamond BioFund Inc. |
| Hsiu-Ming Lin | Chairman, Taiwan Stock Exchange Corporation | ||
| Li-Chung Chien | Chairman, Taipei Exchange | ||
| 09:30 ╷ 09:55 |
AI & synthesis: proteins, cell-types, connectomes, organs | George M. Church | Professor, Health Sciences and Technology at Harvard and Massachusetts Institute of Technology |
| 09:55 ╷ 10:15 |
The Next Step for Taiwan's Biotech Industry | Ming-Hsin Kung | Secretary-General, Executive Yuan |
| 10:15 ╷ 10:35 |
Trends in the Global Healthcare Capital Market | Ling Zhang | Managing Director/ Head of Asia Pacific Healthcare Investment Banking, Citi |
| 10:35 ╷ 10:55 |
Taiwan’s Biotech Industry: Capital Market Landscape and Outlook | Hui-Chuan Tu | Senior Executive Vice President, Taiwan Stock Exchange Corporation |
| 10:55 ╷ 11:05 |
Break | ||
| 11:05 ╷ 12:00 |
Panel 1: From Capital to Impact: Driving Biotech Innovation and Value |
*David P.W. Lau | Managing Director/ Head of Asia Healthcare Investment Banking, J.P. Morgan |
| Yuan-Tsan Chiu | Executive Vice President, Taiwan Stock Exchange Corporation | ||
| Shiing-Jer Twu | Chairman, Development Center for Biotechnology | ||
| Han-Chung Wu | Director of Biomedical Translation Research Center, Academia Sinica | ||
| Andrew Lin | Chairman, BRIM Biotechnology, Inc. | ||
| Bobby Sheng | Chairman, Bora Pharmaceuticals Co., Ltd. | ||
| 12:00 ╷ 13:00 |
Luncheon | ||
| 13:00 ╷ 13:30 |
TBF Biotechnology Lecture & Wu Ho-Su Award Ceremony | Pan-Chyr Yang Chi-Huey Wong Thomas Wu |
Chairman, Taiwan Bio-development Foundation Founder, Taiwan Bio-development Foundation Chairman, TS Financial Holding Co., Ltd. |
| 13:40 ╷ 14:05 |
Empowering Biotech Development through Taipei Exchange | Flora Li | Deputy CEO, Taipei Exchange |
| 14:05 ╷ 14:30 |
The Future of Medical AI: A Capital Market Perspective | Jun Wu | Managing Director, Head of Asia Healthcare, Jefferies |
| 14:30 ╷ 14:55 |
Emerging biotech VC trends | John Tsai | Executive Partner, Syncona Investment Management |
| 14:55 ╷ 15:20 |
Asia biopharma innovation and investment opportunities | Shuntaro Kodama | Managing Director, DCI Partners Co., Ltd. |
| 15:20 ╷ 16:20 |
Panel 2 Navigating Biotech Venture Investment in an Uncertain Global Landscape |
*Pan-Chyr Yang | Chairman, Diamond BioFund Inc. |
| John Tsai | Executive Partner, Syncona Investment Management | ||
| Shuntaro Kodama | Managing Director, DCI Partners Co., Ltd. | ||
| Alex Yuen | Managing Director, Head of China Equity Capital Markets and Syndicate, Jefferies | ||
| David Zhu | Founding Partner, Kendall Capital Partners | ||
| Yen-Chen Huang | Vice President, Diamond BioFund Inc. | ||
| 16:20 ╷ 16:35 |
Break | ||
| 16:35 ╷ 17:00 |
Company Presentation | REVIVEBIO Co., Ltd. | |
| 17:00 ╷ 17:25 |
Tetanti AgriBiotech Inc. | ||
| 17:25 ╷ 17:50 |
StemCyte Taiwan Co., Ltd. | ||
| 17:50 ╷ 18:00 |
Closing | ||
B.Roadshow
08/11 W hotel 8F (Great Room)
| Time | Company Presentation |
| 13:35 - 14:00 |  |
| 14:00 - 14:25 | 
|
| 14:25 - 14:50 |  |
| 14:50 - 15:15 | 
|
| 15:15 - 15:40 |  |
| 15:40 - 16:05 |  |
| 16:05 - 16:30 |  |
C.One-on-one Partnering
The partnering platform is launched on November 1st.
The platform gathers specialists from biotech industry, venture capital or academic
organizations. You may invite companies to open a talk about industrial trend or gain the update news about
the technical and product information. Moreover, you may have business partnering if you would like to
search for partnership or fund raising. Last but not least, you could expend the networking through the
partnering session. Please fill in the company profile via member center. Once the organizer reviews the
information completeness, you could start the partnering on 11/1.